Pathology
New Device Retrieves Circulating Tumor Cells Without Biochemical Labeling
A new device has been developed for improved cancer diagnosis and monitoring, without biochemical markers, that uses a noninvasive “liquid biopsy” approach for cancer screening, diagnosis, staging, personalized medication, and treatment monitoring. More...18 Jun 2013
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Clinical Chemistry System
P780
ESR Analyzer
TEST1 2.0
In Other News
Lung Cancer Diagnostic Gene Mutation Test Approved
Genetic Risk Factors Identified for Testicular Cancer
Gene Expression Tests Helps Tailor Cancer Treatments
Gene Test Estimates Breast Cancer Recurrence
Chemoresponse Assay Improves Ovarian Cancer Survival Rates
Genetic Markers Linked to Development of Lymphedema
Tests Provide Fuller Picture of Cancer Mutations
Biomarkers Found for Metastatic Breast Tumor Cells
Serum Metabolomics Diagnoses Pancreatic Cancer
DNA Test Detects Mutations Across Multiple Genes
Blood Test Tracks Response to Cancer Treatment
Genetic Markers Improve Predictive Performance for Prostate Cancer
Biomarkers Predict Progression to Adenocarcinoma
Nanochip Device Identifies Melanoma Cells
Assay Targets Early Lung Cancers for Adjuvant Therapy
Rapid Technology Identifies Cancer Gene Status
Genetic Susceptibility Loci Identified for Colorectal Tumors
Genetic Root Identified For Early-Onset Prostate Cancer
Molecular Blood Test Detects Colorectal Cancer
Genetic Test Identifies Small but Deadly Lung Cancers
Test Predicts Harmful Breast Cancer Mutations
Microbiological Molecular Assay Analyses Heart Valve Tissue
Blood Test Predicts Breast Cancer Recurrence
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.